Modalités pratiques d’une sédation en phase terminale ou en fin de vie en pédiatrie : prise de décision, mise en œuvre et surveillance

[1]  M. Viallard,et al.  Indication d’une sédation en phase terminale ou en fin de vie chez l’enfant : propositions à partir d’une synthèse de la littérature , 2010 .

[2]  F. Bernard,et al.  692 SEDATION USING KETAMINE FOR PAIN PROCEDURES IN PEDIATRIC ONCOLOGY , 2009 .

[3]  F. Bernard,et al.  [Sedation using ketamine for pain procedures in Pediatric Oncology.]. , 2009, Bulletin du cancer.

[4]  G. Mion,et al.  Sédation-analgésie en réanimation (nouveau-né exclu) , 2008 .

[5]  O. Linderkamp,et al.  Gamma-Hydroxybutyric Acid Sedation in Neonates and Children Undergoing MR Imaging , 2007, Klinische Padiatrie.

[6]  J. Weeks,et al.  Parent and physician perspectives on quality of care at the end of life in children with cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Hubert,et al.  Limitations et arrts de traitements actifs en ranimation pdiatrique: recommandations du GFRUP , 2005 .

[8]  D. Tibboel,et al.  Assessment of sedation levels in pediatric intensive care patients can be improved by using the COMFORT “behavior” scale* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[9]  G. Blike,et al.  Review of Pediatric Sedation , 2004, Anesthesia and analgesia.

[10]  G. Steineck,et al.  Talking about death with children who have severe malignant disease. , 2004, The New England journal of medicine.

[11]  Lawrence Wolfe.  Should parents speak with a dying child about impending death? , 2004, The New England journal of medicine.

[12]  Nicola Latronico,et al.  The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome , 2003, Intensive Care Medicine.

[13]  N. Graf,et al.  Gamma-hydroxybutyrate versus chlorprothixene/phenobarbital sedation in children undergoing MRI studies. , 2003, Klinische Padiatrie.

[14]  E. Emanuel,et al.  Symptoms and suffering at the end of life in children with cancer. , 2000, The New England journal of medicine.

[15]  M. O'riordan,et al.  Efficacy and safety of atropine-midazolam-ketamine in pediatric oncology patients , 1999 .

[16]  M. Dehan,et al.  Midazolam and myoclonus in neonate , 1994, European Journal of Pediatrics.

[17]  G. Rudkin,et al.  Intraoperative patient‐controlled sedation. Comparison of patient‐controlled propofol with patient‐controlled midazolam , 1992 .

[18]  J. Blumer,et al.  Assessing distress in pediatric intensive care environments: the COMFORT scale. , 1992, Journal of pediatric psychology.

[19]  B. Roth,et al.  Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit , 1991, European Journal of Pediatrics.

[20]  V. Fodale,et al.  Propofol Infusion Syndrome , 2008, Drug safety.